Evidence map›Paper›PMID 22982377›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2012

A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates.

Melissa A Suter, Aishe Chen, Marie S Burdine, Mahua Choudhury, R Alan Harris, Robert H Lane, Jacob E Friedman, Kevin L Grove, Alan J Tackett, Kjersti M Aagaard

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02211651 (Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes), which is not on this map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02211651 completednot on this mapstarted 2013, after this paper: background citation

Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)

TypeobservationalSponsorAdventHealth Translational Research InstituteRan2013 to 2017Enrolled3ConditionsObesity, Type 2 Diabetes
3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 171 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Role of cellular senescence in hepatic diseases (Review).International journal of molecular medicine · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Melissa A SuterDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Aishe Chen
Marie S Burdine
Mahua Choudhury
R Alan Harris
Robert H Lane
Jacob E Friedman
Kevin L Grove
Alan J Tackett
Kjersti M Aagaard
Baylor College of Medicine · USUniversity of Arkansas for Medical Sciences · USUniversity of Colorado Denver · USOregon Health & Science University · USUniversity of Utah · US

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
The Impact of Maternal Health and Diet on Development of Fetal Metabolic SystemsR24DK090964 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI AAGAARD, KJERSTI MARIE, FRIEDMAN, JACOB E · 2010 to 2019
$15.8M
Research Education and Career Horizons ProgramK12GM084897 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI SIFERS, RICHARD NORMAN, SLAUGHTER, GAYLE · 2008 to 2016
$8.3M
Maternal High Fat Diet and Melanocortin System in OffspringR01DK079194 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI KIEVIT, PAUL · 2007 to 2015
$6.2M
Conserved Fetal Epigenomic Signatures in a Primate Model of Maternal ObesityR01DK089201 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI AAGAARD, KJERSTI MARIE · 2012 to 2021
$5.1M
Characterization of the Fetal Primate Epigenome and Metabolome Under In UteroDP2OD001500 · OD · BAYLOR COLLEGE OF MEDICINE · PI AAGAARD, KJERSTI MARIE · 2007 to 2011
$2.3M
Development of technology for high resolution epigenetic profiling of chromatinR01DA025755 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI TACKETT, ALAN, TAVERNA, SEAN D. · 2008 to 2011
$1.6M
MECHANISMS FOR FETAL HEPATIC PROGRAMMING IN THE NON-HUMAN PRIMATE (NHP)R01DK078590 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI FRIEDMAN, JACOB E · 2007 to 2010
$1.5M
Maternal Diet Modifies the Fetal Primate Epigenome and Circadian Gene ExpressionR01DK080558 · NIDDK · UNIVERSITY OF UTAH · PI LANE, ROBERT H · 2007 to 2010
$987k
NIDA NIH HHS R01 DA025755NIDA NIH HHS R01DA025755NIDDK NIH HHS 5R01DK078590NIDDK NIH HHS DK79194NIDDK NIH HHS P30 DK020593NIDDK NIH HHS R01 DK078590NIDDK NIH HHS R01 DK079194NIDDK NIH HHS R01 DK080558NIDDK NIH HHS R01DK080558-01NIDDK NIH HHS R01 DK089201NIDDK NIH HHS R24 DK090964NIGMS NIH HHS K12 GM084897NIH HHS DP2120OD001500-01NIH HHS DP2 OD001500PHS HHS R000163
6 · The paper itself

Abstract

In nonhuman primates, we previously demonstrated that a maternal high-fat diet (MHFD) induces fetal nonalcoholic fatty liver disease (NAFLD) and alters the fetal metabolome. These changes are accompanied by altered acetylation of histone H3 (H3K14ac). However, the mechanism behind this alteration in acetylation remains unknown. As SIRT1 is both a lysine deacetylase and a crucial sensor of cellular metabolism, we hypothesized that SIRT1 may be involved in fetal epigenomic alterations. Here we show that in utero exposure to a MHFD, but not maternal obesity per se, increases fetal H3K14ac with concomitant decreased SIRT1 expression and diminished in vitro protein and histone deacetylase activity. MHFD increased H3K14ac and DBC1-SIRT1 complex formation in fetal livers, both of which were abrogated with diet reversal despite persistent maternal obesity. Moreover, MHFD was associated with altered expression of known downstream effectors deregulated in NAFLD and modulated by SIRT1 (e.g., PPARΑ, PPARG, SREBF1, CYP7A1, FASN, and SCD). Finally, ex vivo purified SIRT1 retains deacetylase activity on an H3K14ac peptide substrate with preferential activity toward acetylated histone H3; mutagenesis of the catalytic domain of SIRT1 (H363Y) abrogates H3K14ac deacetylation. Our data implicate SIRT1 as a likely molecular mediator of the fetal epigenome and metabolome under MHFD conditions.

Indexed as

Diet, High-FatAcetylationAnimalsBlotting, WesternCatalytic DomainCOS CellsFemaleFetusGene Expression Regulation, DevelopmentalHistone DeacetylasesHistonesLiverLysineMacacaMaleMass SpectrometryHistone DeacetylasesHistonesLysinep300-CBP Transcription FactorsSirtuin 1

Identifiers

PMID22982377
PMCPMC3509051
OpenAlexW1981379568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.